MIAtek® technology

MIAtek® technology

MIAtek®'s breakthrough technology, developed by Magnisense is protected by a strong patent intellectual property strategy with formalized expertise (ISO13485). Patents have been granted in Europe, the United States and in Japan as well as other regions.


MIAtek® technology can measure a low concentrations of proteins, peptides and micro-organisms in complex biological samples such as whole blood, in just minutes, using a robust, portable, user-friendly and economical instrument.

 

MIAtek® technology is based on the unique use of magnetic nanoparticles as labels to detect super-paramagnetic signals. The biological reaction takes place on the consumable. During the reaction, the magnetic beads specifically bind to the selected marker present in the biological matrix. Then the consumable is inserted in the reading head of the instrument. The magnetic signal generated by the beads, specifically bound to the marker, is measured and then directly correlated to the markers in order to determine the concentration of antigens.